top of page

Bdparib 300 mg Tablet

SKU BDR Pharmaceuticals Pvt Ltd
Original price

$611.97

Sale price

$477.34

Bdparib 300 mg Tablet is an innovative treatment option designed to combat specific types of cancer, including ovarian, fallopian tube, and peritoneal cancers. As a member of the PARP inhibitor class, this medication is particularly effective for patients with BRCA gene mutations, as it inhibits the cancer cells' ability to repair their damaged DNA, thus hindering tumor proliferation. By targeting the underlying mechanisms of these malignancies, Bdparib helps to enhance treatment outcomes for individuals facing these challenging diagnoses. Patients should be aware of potential side effects, such as nausea and fatigue, and must discuss any existing health conditions with their healthcare provider before starting therapy. It's crucial to follow dosing instructions carefully to maximize the benefits while minimizing risks. With its focused approach, Bdparib represents a significant advancement in personalized cancer treatment, making it an essential option for eligible patients. Always consult with a healthcare professional for tailored advice and comprehensive information on this medication.

Quantity

Active Pharmaceutical Ingredient

Rucaparib 300 mg

Uses

• Bdparib 300 mg tablet is primarily used in the treatment of advanced ovarian cancer. It helps inhibit cancer cell growth by targeting specific enzymes involved in DNA repair. This mechanism is particularly beneficial for patients with BRCA mutations. By disrupting the cancer cells' ability to repair their DNA, Bdparib 300 mg tablet can enhance treatment outcomes.
• In addition to ovarian cancer, Bdparib 300 mg tablet is effective for treating fallopian tube cancer. This type of cancer shares similar characteristics with ovarian cancer, making Bdparib a suitable option. The tablet works by targeting the underlying genetic factors that contribute to tumor growth. Patients may experience improved management of their condition while on this treatment.
• Bdparib 300 mg tablet is also indicated for primary peritoneal cancer, which is closely related to ovarian cancer. This medicine plays a crucial role in managing the disease by interfering with the cancer cells' ability to survive. It is particularly useful for patients who have received prior treatments and are looking for additional therapeutic options. By utilizing Bdparib 300 mg tablet, patients may achieve better control over their cancer progression.
• Furthermore, Bdparib 300 mg tablet is utilized in the treatment of castration-resistant prostate cancer. This advanced stage of prostate cancer occurs when the disease continues to progress despite hormone therapy. Bdparib acts by targeting specific pathways that are essential for cancer cell survival. This targeted approach can offer new hope for patients facing this challenging condition.

Benefits

Bdparib 300 mg Tablet offers significant advantages in the treatment of certain cancers. As a PARP inhibitor, rucaparib is particularly effective in targeting cancer cells with BRCA gene mutations. By inhibiting the ability of these cells to repair DNA damage, rucaparib helps to slow or stop tumour growth. This mechanism of action is particularly beneficial for patients with ovarian, fallopian tube and peritoneal cancers, where BRCA mutations are common. In addition, Bdparib 300 mg Tablet has been shown to extend progression-free survival in patients, giving them more time before their cancer progresses. For many patients, rucaparib can improve quality of life by shrinking tumours and relieving cancer-related symptoms. The convenience of oral administration also makes rucaparib a practical option for long-term treatment, allowing patients to maintain their daily routines with minimal disruption. Overall, Bdparib 300 mg represents a valuable therapeutic option that offers hope and prolonged survival for people living with BRCA-mutated cancers.

Side Effects

Many side effects go away on their own as your body gets used to the Bdparib 300 mg Tablet. If they stick around or if you're concerned, talk to your doctor.

Most Common Side Effects

• Nausea
• vomiting
• Constipation
• Diarrhea
• Sneezing
• Throat pain or itching
• Abdominal pain
• Loss of Appetite
• Trouble in Concentration
• Insomnia

Common Side Effects

• Myelodysplastic Syndrome
• Acute Myeloid Leukemia
• Shortness of breath
• Pale skin
• Rashes
• unusual bruising or bleeding
• Blood in Stool and Urine

How To Use

Bdparib 300 mg Tablet comes in an oral tablet form that can be taken with or without food, as instructed by your doctor. Your healthcare provider may adjust the dosage based on the severity of your condition or how well you tolerate the medication. Always store rucaparib in a sealed container at room temperature, keeping it away from direct sunlight and moisture. It is not recommended for use during pregnancy and breastfeeding, as its safety for these patients has not been established.

Safety Advice

• Alcohol: The safety of drinking alcohol while taking Bdparib 300 mg Tablet is unknown. It is great to invite your physician for advice.
• Kidney: Bdparib 300 mg is perfectly safe for patients with kidney problems. There's no need to adjust the dose for these patients.
• Breastfeeding: Bdparib 300 mg Tablet is likely unsafe for use while breastfeeding. Limited information from human studies indicates that the drug may enter breast milk and could potentially harm the baby.
• Liver: Bdparib 300 mg Tablet is perfectly safe for patients with liver problems. There's no need to adjust the dose for these patients.
• Pregnancy: Bdparib 300 mg Tablet might not be safe to use during pregnancy. While human studies are limited, animal research has shown that it could harm the developing baby. Your doctor will carefully consider the benefits and possible risks before prescribing it. Make certain to seek advice from your doctor.
• Driving: There isn't enough information to say whether taking Bdparib 300 Tablet affects your ability to drive. If you experience symptoms that make it difficult to concentrate or react, you should avoid driving.

bottom of page